miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9

Oncology Letters

Volumn 11, Issue 2, 2016, Pages 945-952

  Wu, Lin ^a   Pu, Xingxiang ^a   Wang, Qianzhi ^a   Cao, Jun ^a   Xu, Fang ^a   Xu, Li ^a   Li, Kang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Chemoresistance; Cisplatin; MiR 96; Non small cell lung cancer; SAMD9

Indexed keywords

CISPLATIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 96; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IC50; LENTIVIRINAE; LUCIFERASE ASSAY; MTT ASSAY; NON SMALL CELL LUNG CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STERILE ALPHA MOTIF DOMAIN CONTAINING GENE; WESTERN BLOTTING;

EID: 84954357443     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.4000     Document Type: Article

References (17)

1. Ma L, Huang Y, Zhu W, et al: An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One 6: e26502, 2011.
2. Merk J, Rolff J, Dorn C, Leschber G and Fichtner I: Chemoresistance in non-small-cell lung cancer: Can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? Eur J Cardiothorac Surg 40: e29-e33, 2011.
3. Chang A: Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71: 3-10, 2011.
4. Asou H, Matsui H, Ozaki Y, et al: Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. Biochem Biophys Res Commun 383: 245-251, 2009.
5. Li CF, MacDonald JR, Wei RY, et al: Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics 8: 92, 2007.
6. Ma Q, Yu T, Ren YY, Gong T and Zhong DS: Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer. Biochem Biophys Res Commun 454: 157-161, 2014.
7. Feng B, Wang R and Chen LB: Review of miR-200b and cancer chemosensitivity. Biomed Pharmacother 66: 397-402, 2012.
8. Van Den Broeck A, Ozenne P, Eymin B and Gazzeri S: Lung cancer: A modified epigenome. Cell Adh Migr 4: 107-113, 2010.
9. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Filipowicz W, Jaskiewicz L, Kolb FA and Pillai RS: Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 15: 331-341, 2005.
11. Byun K, Bayarsaikhan E, Kim CY, Mook-Jung I, Paek SH, Kim SU, Yamamoto T, Won MH, Song BJ, et al: Induction of neuronal death by microglial AGE-albumin: Implications for Alzheimer's disease. PLoS ONE 7: e37917, 2012
12. Garcia DM, Baek D, Shin C, Bell GW, Grimson A and Bartel DP: Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146, 2011.
13. Liu M, Wang J, Huang H, Hou J, Zhang B and Wang A: miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. Biochem Biophys Res Commun 441: 364-370, 2013.
14. Xia H, Chen S, Chen K, Huang H and Ma H: MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer. Biomed Pharmacother 68: 951-958, 2014.
15. Li J, Li P, Chen T, Gao G, Chen X, Du Y, Zhang R, Yang R, Zhao W, Dun S, Gao F, et al: Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumour Biol 36: 685-692, 2015.
16. Feng J, Yu J, Pan X, Li Z, Chen Z, Zhang W, Wang B, Yang L, Xu H, Zhang G and Xu Z: HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Oncotarget 5: 5832-5844, 2014.
17. Rosenberg B, VanCamp L, Trosko JE and Mansour VH: Platinum compounds: A new class of potent antitumour agents. Nature 222: 385-386, 1969.